Total for the last 12 months
number of access : ?
number of downloads : ?
ID 116997
Title Alternative
SHED-CM for ALS Treatment
Author
Ueda, Tomoyuki Gifu Pharmaceutical University
Ito, Taisei Gifu Pharmaceutical University
Inden, Masatoshi Gifu Pharmaceutical University
Kurita, Hisaka Gifu Pharmaceutical University
Hozumi, Isao Gifu Pharmaceutical University
Keywords
amyotrophic lateral sclerosis
copper-zinc superoxide dismutase 1
stem cells from human exfoliated deciduous teeth
induced pluripotent stem cells
aggregation
Content Type
Journal Article
Description
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder, characterized by the loss of upper and lower motor neurons, for which an effective treatment has yet to be developed. Previous reports have shown that excessive oxidative stress, related to mitochondrial dysfunction and the accumulation of misfolding protein, contributes to ALS pathology. In terms of treatment, it remains necessary to identify effective medicines for multiple therapeutic targets and have additive effects against several disorders. In this study, we investigated stem cells from human exfoliated deciduous teeth (SHED), which release many factors, such as neurotrophic factors and cytokines, and are applied to treat neurological diseases. Specifically, we examined whether SHED-conditioned medium (CM), i.e., the serum-free culture supernatant of SHED, reduced mutant SOD1-induced intracellular aggregates and neurotoxicity. We found that SHED-CM significantly suppressed the mutant SOD1-induced intracellular aggregates and neurotoxicity. The neuroprotective effects of SHED-CM are partly related to heat shock protein and the activation of insulin-like growth factor-1 receptor. SHED-CM also had a protective effect on induced pluripotent stem cell-derived motor neurons. Moreover, SHED-CM was effective against not only familial ALS but also sporadic ALS. Overall, these results suggest that SHED-CM could be a promising treatment for slowing the progression of ALS.
Journal Title
Frontiers in Pharmacology
ISSN
16639812
Publisher
Frontiers Media S.A.
Volume
13
Start Page
805379
Published Date
2022-02-03
Rights
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
EDB ID
DOI (Published Version)
URL ( Publisher's Version )
FullText File
language
eng
TextVersion
Publisher
departments
Oral Sciences